Literature DB >> 22634823

[The role of the community health agent in control of the in-house stock of medication in communities served by the family health strategy].

Gabriela Laste1, Alícia Deitos, Carla Kauffmann, Luís César de Castro, Iraci Lucena da Silva Torres, Luciana Carvalho Fernandes.   

Abstract

The scope of this study was to investigate the in-house stock of medication in communities served by the Family Health Strategy (FHS) in a city located in the south of Brazil. A sample of 10% of households in five FHS areas was studied. Data were collected by Community Healthcare Workers using the adapted Fernandes questionnaire (2000). The mean age of the interviewees was 42 years and of the residents was 16 years, 51% of which were female. Low income (1 to 3 minimum wages) was observed (69.1%), and low education levels (0 to 4 years of study) (42%). Of the households visited 98.7% had at least one medication in stock. In 533 of the storage places located, 43.5% of such places were exposed to heat, 39.6% were exposed to humidity and 16.51% to light. Of the 2,717 medicines found, 6.9% were past the validity date, 35.3% were not in the secondary wrapping and 67.9% were without the patient information leaflet. Analgesics were the most common medications in in-house stock (21%). This study revealed the need for a multi-professional team to promote health and the rationalization of in-house stock since the Community Healthcare Worker is an indispensable professional to promote the rational use of medication.

Entities:  

Mesh:

Year:  2012        PMID: 22634823     DOI: 10.1590/s1413-81232012000500024

Source DB:  PubMed          Journal:  Cien Saude Colet        ISSN: 1413-8123


  1 in total

1.  Prevalence of self-medication in Brazil and associated factors.

Authors:  Paulo Sérgio Dourado Arrais; Maria Eneida Porto Fernandes; Tatiane da Silva Dal Pizzol; Luiz Roberto Ramos; Sotero Serrate Mengue; Vera Lucia Luiza; Noemia Urruth Leão Tavares; Mareni Rocha Farias; Maria Auxiliadora Oliveira; Andréa Dâmaso Bertoldi
Journal:  Rev Saude Publica       Date:  2016-12       Impact factor: 2.106

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.